// App-Quantinova.ai

Sa1998 : GRP78, a Prognostic Marker for Colorectal Cancer, Is Modulated by SPARC to Promote Endoplasmic Reticulum-Stress Mediated Apoptosis

Researchers

Presenter

  • David F. Schaeffer

Principal Investigators

  • Hagen Kennecke

  • Howard Lim

  • Hla Win-Piazza

  • Isabella T. Tai

Medical Centers

  • Michael Smith Genome Sciences Center, British Columbia Cancer Agency Cancer Research Center, Vancouver, BC, Canada

  • Faculty of Medicine, University of British Columbia, Vancouver, BC, Canada

  • Department of Medical Oncology, British Columbia Cancer Agency, Vancouver, BC, Canada

  • The University of British Columbia, Vancouver, BC, Canada

Locations

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Colorectal Cancer

Biomarkers

  • Nucleoside diphosphate kinase A

  • DNA Damage Inducible Transcript 3

Drug/Treatment

  • Tunicamycin

  • Cysteine Hydrochloride

  • Adrucil injection

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved